Shining a spotlight on sarcopenia and myosteatosis in liver disease and liver transplantation

Documenti analoghi

• Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction‐associated steatotic liver disease?
  di: Guillaume Henin, et al.
  Pubblicazione: (2024)
• Thy‐1 restricts steatosis and liver fibrosis in steatotic liver disease
  di: Valentin Blank, et al.
  Pubblicazione: (2024)
• Waitlist and transplant outcomes in patients with metabolic dysfunction‐associated steatotic liver disease and autoimmune hepatitis
  di: Esli Medina‐Morales, et al.
  Pubblicazione: (2024)
• The associations between fibrosis changes and liver‐related events in patients with metabolic dysfunction‐associated steatotic liver disease
  di: Hye Won Lee, et al.
  Pubblicazione: (2024)
• Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity
  di: Rachel B. Schenker, et al.
  Pubblicazione: (2024)